Franklin Resources’s Disc Medicine IRON Stock Holding History

Franklin Resources’s Portfolio IRON Stock Details IRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-102,016	Closed	-$6.35M	–	2916
2024 Q1	$6.35M	Sell	102,016 -119,408	-54%	-$7.74M	﹤0.01%	1238
2023 Q4	$12.8M	Buy	221,424 +60,403	+38%	+$3.09M	0.01%	879
2023 Q3	$7.56M	Buy	161,021 +3,766	+2%	+$188K	﹤0.01%	965
2023 Q2	$6.98M	Buy	+157,255	New	+$5.58M	﹤0.01%	1017
2022 Q2	–	Sell	-35,726	Closed	-$1.49M	–	2414
2022 Q1	$1.49M	Sell	35,726 -48,033	-57%	-$2.52M	﹤0.01%	1500
2021 Q4	$7.31M	Hold	83,759	–	–	﹤0.01%	1135
2021 Q3	$10.2M	Buy	83,759 +30,239	+57%	+$4.13M	﹤0.01%	1051
2021 Q2	$10.4M	Buy	53,520 +36,853	+221%	+$12.1M	﹤0.01%	1002
2021 Q1	$6.78M	Buy	+16,667	New	+$7.43M	﹤0.01%	1057

Other funds holding IRON

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Franklin Resources's IRON Position: Q2 2024 in Review

Franklin Resources sold out of Disc Medicine (IRON) in Q2 2024, closing a stake of 102,016 shares — an estimated $6.35M sold.

Franklin Resources first reported a position in IRON in Q1 2021 and held it in 9 quarters. The position peaked at $12.8M in Q4 2023. 121 funds tracked by Wall St. Rank hold IRON as of Q2 2024.

Franklin Resources reported no remaining Disc Medicine position as of Q2 2024 after selling out during the quarter.
Franklin Resources sold 102,016 Disc Medicine shares in Q2 2024, an estimated $6.35M.
Franklin Resources first reported a position in Disc Medicine in Q1 2021 and held it in 9 quarters.
Franklin Resources's Disc Medicine position peaked at $12.8M in Q4 2023.
121 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2024.

Based on Franklin Resources's 13F filing for Q2 2024, filed 14 Aug 2024.